Thomas P. Theriault
Incyte
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Thomas P. Theriault.
Drug Discovery Today: Targets | 2004
Benjamin G. Cocks; Thomas P. Theriault
Abstract siRNA technology provides a useful means of achieving reduction of gene expression in mammalian cells. In this article we focus on recent advances that make siRNA technology more practical as a tool for target validation. New advances include better use of sequence databases to assist in the design of reagents and improved diligence in the evaluation of target and off-target effects using appropriate controls and gene expression microarrays. The new developments will allow progress in the evaluation of individual targets and target combinations and will enable comprehensive efforts to define mammalian cell processes.
Trends in Biotechnology | 1998
Mark Schena; Renu A. Heller; Thomas P. Theriault; Ken Konrad; Eric Lachenmeier; Ronald W. Davis
Archive | 1996
Ronald C. Gamble; Thomas P. Theriault; John D. Baldeschwieler
Archive | 1996
Ronald C. Gamble; Thomas P. Theriault; John D. Baldeschwieler
Archive | 1997
Ronald C. Gamble; Thomas P. Theriault; John D. Baldeschwieler
Archive | 1996
Ronald C. Gamble; Thomas P. Theriault; Scott C. Winder
Archive | 1999
Lyle Arnold; Tod Bedilion; Erik Bjeldanes; Thomas P. Theriault; Warren Lei
Archive | 2000
Lyle Arnold; Tod Bedilion; Erik Bjeldanes; Thomas P. Theriault; Warren Lei
Archive | 1997
Ronald C. Gamble; Thomas P. Theriault; Scott C. Winder
Archive | 2000
Lyle Arnold; Tod Bedilion; Erik Bieldanes; Thomas P. Theriault; Warren Lei